CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-30 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,000 | $0.30 | $3K | 151,835 |
| 2015-09-30 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,000 | 245,022 | ||
| 2015-09-30 | Biller Scott Chief Scientific Officer | Exercise or conversion | +5,500 | $31.64 | $174K | 39,570 |
| 2015-09-30 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $70.44 | $387K | 34,070 |
| 2015-09-30 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 290,880 | ||
| 2015-09-25 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $82.09 | $199K | 147,854 |
| 2015-09-25 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $82.07 | $199K | 147,854 |
| 2015-09-24 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +10,000 | 10,000 | ||
| 2015-09-24 | Goddard Glenn Senior Vice President, Finance | Shares withheld for taxes | −4,856 | $88.89 | $432K | 5,144 |
| 2015-09-24 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +856 | $23.10 | $20K | 6,000 |
| 2015-09-24 | Goddard Glenn Senior Vice President, Finance | Sale | −6,000 | $85.97 | $516K | 0 |
| 2015-09-24 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Restricted stock units | −10,000 | 0 | ||
| 2015-09-24 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −856 | 88,242 | ||
| 2015-09-24 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $84.43 | $205K | 150,280 |
| 2015-09-24 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $84.42 | $205K | 150,280 |
| 2015-09-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +2,480 | $0.30 | $750 | 144,315 |
| 2015-09-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +17,520 | $0.30 | $5K | 161,835 |
| 2015-09-15 | Higgons John Duncan Chief Operating Officer | Sale | −20,000 | $91.11 | $1.8M | 141,835 |
| 2015-09-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −2,480 | 272,542 | ||
| 2015-09-15 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −17,520 | 255,022 |
Page 86 of 93 · 1,853 trades